Nocturnal oxygen therapy as an option for early COVID-19

There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Chongxing, Yue, Xiaofeng, Wang, Jianwu, Shi, Chunmeng, Li, Weibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319633/
https://www.ncbi.nlm.nih.gov/pubmed/32599285
http://dx.doi.org/10.1016/j.ijid.2020.06.080
Descripción
Sumario:There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability.

Ejemplares similares